Alemtuzumab in relapsed immune severe aplastic anemia: Long-term results of a phase II study. Aggarwal N, Manley AL, Shalhoub R, Durrani J, et al. Am J Hematol 2023 Apr 6. doi: 10.1002/ajh.26924.

Read + Share

Amedeo Smart

Independent Medical Education

Aggarwal N, Manley AL, Shalhoub R, Durrani J, et al. Alemtuzumab in relapsed immune severe aplastic anemia: Long-term results of a phase II study. Am J Hematol 2023 Apr 6. doi: 10.1002/ajh.26924.
PMID: 37021397